Sandu Pharmaceuticals Ltd Share Price
(524703)
₹49▲5.99%
as on 04:01PM, 28 Mar 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 0.41 % |
3 Month Return | -14.44 % |
1 Year Return | -17.23 % |
Market Stats | |
Previous Close | ₹46.23 |
Open | ₹51.00 |
Volume | 5,959.00 |
Upper Circuit | ₹55.47 |
Lower Circuit | ₹36.99 |
Market Cap | ₹47.33Cr |
P/E Ratio
16.61
PEG Ratio
11.07
Market Cap
₹47.33 Cr
P/B Ratio
1.37
EPS
1.51
Dividend Yield
1.39
Sector
Pharmaceuticals
ROE
3.66
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, 0.17 Cr → 0.5 Cr (in ₹), with an average increase of 66.0% per quarter
Revenue Rich
Revenue is up for the last 3 quarters, 15.91 Cr → 17.73 Cr (in ₹), with an average increase of 5.3% per quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.2% return, outperforming this stock by 161.6%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 42.90% of holdings in Dec 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 57.09% of holdings in Dec 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 61.9% return, outperforming this stock by 79.1%
Price Dip
In the last 3 years, Sandu Pharma. stock has moved down by -30.4%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 42.9% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 57.09% | 0.00 | |
Others | 0.01% | 0.00 |
Sandu Pharmaceuticals Ltd in the last 5 years
Lowest (15.67x)
March 27, 2025
Today (16.61x)
March 28, 2025
Industry (53.18x)
March 28, 2025
Highest (66.08x)
February 19, 2024
Sandu Pharmaceuticals Ltd’s net profit fell -9.09% since last year same period to ₹0.50Cr in the Q2 2024-2025. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated 194.12% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending June 2024, Sandu Pharmaceuticals Ltd has declared dividend of ₹0.80 - translating a dividend yield of 3.16%.
Read More about DividendsBearish
Neutral
Bullish
Sandu Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹47.33 Cr | 63.39% | 0.50 | ₹1 Cr | ₹67 Cr | |
NA | ₹15.80 Cr | 32.8% | 0.99 | NA | NA | |
NA | ₹86.49 Cr | 48.83% | 0.73 | NA | NA | |
BUY | ₹10,081.53 Cr | 300.1% | 0.51 | ₹314 Cr | ₹2,177 Cr | |
NA | ₹167.89 Cr | -6.09% | 0.58 | NA | NA |
Organisation | Sandu Pharmaceuticals Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Sandu Pharmaceuticals Ltd share price today stands at ₹49, Open: ₹51, Previous Close: ₹46.23, High: ₹51, Low: ₹47, 52 Week High: ₹69.5, 52 Week Low: ₹45.15.
Today's traded volume of Sandu Pharmaceuticals Ltd(524703) is 5,959.00.
Today's market capitalisation of Sandu Pharmaceuticals Ltd(524703) is ₹47.33Cr.
Sandu Pharmaceuticals Ltd (524703) share price is ₹49. It is down -29.50% from its 52 Week High price of ₹69.5
Sandu Pharmaceuticals Ltd (524703) share price is ₹49. It is up 8.53% from its 52 Week Low price of ₹45.15